Our nomogram (Figure 8E)—combining TMEM106A with gender, chemotherapy, age, Karnofsky performance score, tumor grade, and radiotherapy—illustrates individualized survival estimation and could guide treatment intensity or surveillance frequency. Here, TMEM106A is linked to neoplasm.